ArticleDiscover nano2026
Magnetic layered double hydroxide supported gold nanoparticles as a robust and recyclable catalyst for the reduction of 4- nitrophenol and oxidation of alkenes and benzyl alcohols.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In this study, we report the synthesis of a novel magnetic nanocomposite, Fe₃O₄@SiO₂@MgAl-LDH@Au, as an efficient and environmentally benign catalyst for both reduction and oxidation reactions. The mesoporous nanocomposite was well-identified using FT-IR, XRD, EDX, TEM, TGA, FESEM, VSM, BET and XPS analyses. Its catalytic performance was first evaluated in the reduction of 4-nitrophenol to 4-aminophenol, monitored by UV-Vis spectroscopy, which confirmed its remarkable activity in the presence of sodium borohydride as a reducing agent. Furthermore, the catalyst was tested in the oxidation of organic substrates, exhibiting moderate to high conversion and selectivity for benzyl alcohols and alkenes. Notably, Fe
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.